RÉSUMÉ
Besides providing spatial anatomic information on heart valves, real-time three-dimensional echocardiography (3DE) combined with color Doppler has the potential to overcome the limitations of flow quantification inherent to conventional 2D color Doppler methods. Recent studies validated the application of color Doppler 3DE (cD-3DE) for the quantification of regurgitation flow based on the vena contracta area (VCA) and the proximal isovelocity surface area (PISA) methods. Particularly the assessment of VCA by cD-3DE led to a change of paradigm by understanding of the VCA as being strongly asymmetric in the majority of patients and etiologies. This review provides a comprehensive description of the different concepts of cD-3DE-based flow quantification in the setting of different valvular heart diseases and their presentation in recent guidelines.
Sujet(s)
Cardiologie/normes , Échocardiographie tridimensionnelle/normes , Médecine factuelle/normes , Valvulopathies/imagerie diagnostique , Guides de bonnes pratiques cliniques comme sujet , Radiologie/normes , Indice de gravité de la maladie , Systèmes informatiques , AllemagneRÉSUMÉ
Infective endocarditis is an endovascular infection usually caused by bacteria. Mortality rate is still approximately 20 %. To improve patients' prognosis by implementation of current diagnostic and therapeutic evidence, the European Society of Cardiology published an updated version of the guidelines for management of infective endocarditis in 2015. It strengthens the role of imaging modalities like PET/CT for detection of infectious foci when echocardiography remains negative and highlights the use of modern tests for identification of possible pathogens. New diagnostic criteria were introduced to integrate these methods for improved diagnostic sensitivity. Complicated cases should be treated in reference centers with on-site cardiac surgery. The antibiotic and early surgical management should be discussed in a multidisciplinary endocarditis team. A few years ago, the indication for endocarditis prophylaxis was limited to high-risk patients. These recommendations were confirmed in current guidelines.
Sujet(s)
Antibactériens/administration et posologie , Techniques d'imagerie cardiaque/normes , Procédures de chirurgie cardiaque/normes , Cardiologie/normes , Endocardite bactérienne/diagnostic , Endocardite bactérienne/thérapie , Antibactériens/normes , Association thérapeutique/méthodes , Association thérapeutique/normes , Diagnostic différentiel , Échocardiographie/normes , Endocardite bactérienne/microbiologie , Europe , Tomographie par émission de positons couplée à la tomodensitométrie/normes , Guides de bonnes pratiques cliniques comme sujetRÉSUMÉ
A relatively new minimally invasive cardiological procedure, called the MitraClip(™), does not require sternotomy and may have a number of advantages compared with open mitral valve surgery, but its acute impact on the pulmonary circulation and right ventricular function during general anaesthesia is unclear. We prospectively assessed the effects of the MitraClip procedure in 81 patients with or without pulmonary hypertension (defined as mean pulmonary artery pressure > 25 mmHg), who were anaesthetised using fentanyl (5 µg.kg(-1)), etomidate (0.2-0.3 mg.kg(-1)), rocuronium (0.5-0.6 mg.kg(-1)) and isoflurane. Placement of the MitraClip led to a 60% increase in mean (SD) right ventricular stroke work index (from 512 (321) to 820 (470) mmHg.ml.m(-2), p < 0.0001), while mean (SD) pulmonary vascular resistance index decreased by 24% (522 (330) to 399 (244) dyn.s.cm(-5), p < 0.0001), and mean (SD) pulmonary artery pressure decreased by 10% (30 (8) to 27 (8) mmHg, p < 0.0001). Patients with pulmonary hypertension experienced a similar decrease in mean pulmonary artery pressure compared with those without, and they also had a slight reduction in mean (SD) pulmonary artery occlusion pressure (22 (6) down to 20 (6) mmHg, p = 0.044). We conclude that successful MitraClip treatment for mitral regurgitation acutely improves right ventricular performance by reducing right ventricular afterload, regardless of whether patients have pre-operative pulmonary hypertension.
Sujet(s)
Anesthésie générale , Implantation de valve prothétique cardiaque/méthodes , Insuffisance mitrale/chirurgie , Valve atrioventriculaire gauche/chirurgie , Circulation pulmonaire , Fonction ventriculaire droite , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Insuffisance mitrale/physiopathologie , Études prospectives , Débit systolique , Résistance vasculaireSujet(s)
Maladie coronarienne/diagnostic , Maladie coronarienne/chirurgie , Embolie/diagnostic , Embolie/chirurgie , Imagerie multimodale/méthodes , Tomographie par cohérence optique/méthodes , Échographie interventionnelle/méthodes , Sujet âgé , Femelle , Humains , Chirurgie assistée par ordinateurRÉSUMÉ
AIM: Sclerosis distribution, topography and morphology in aortic stenosis may have an impact on the localisation of post-procedural paravalvular leakage (PVL) following transcatheter aortic valve implantation (TAVI). METHODS: Between 05/2005 and 03/2011 a total of 208 patients underwent either transapical (TA) or transvascular (TV) TAVI using the Edwards-SAPIEN(TM), or CoreValve(TM) system. Aortic cusp and annular sclerosis distribution and aortic valve sclerosis symmetry were evaluated by preoperative transesophageal echocardiography (TOE). Mild, moderate and severe PVL after TAVI (group 1, N.=117) were analysed and compared to those patients with no signs of postprocedural PVL (group 2, N.=91). Commercial available image processing and analysing software were used to evaluate all relevant calcific sections (aortic sclerosis score 0-66; symmetry score 0-5) and were matched with the localization of the PVLs. RESULTS: A total of 117 patients (83±6 years, mean logistic EuroSCORE 20.1±12.7%) were identified with a mild-moderate PVL (TV, N.=102; TA, N.=15). Mean aortic sclerosis score was 38.7±7.6 in group 1 compared to 33.7±8.3 in group 2 (P<0.001) showing highest calcification in the non-coronary part for both groups. The mean symmetry score was 1.9±1.0 group 1 compared to 1.7±1.0 in group 2 (P=0.12). Regression analysis showed a significant relation of preoperative cusp localisation to the corresponding paravalvular leakage (P<0.001). CONCLUSION: The present study shows that a aortic sclerosis score constructed by TOE enables prediction of postoperative PVL and moreover, the localisation of PVL after TAVI correlates with the corresponding preoperative amount of sclerosis for each cusp.
Sujet(s)
Insuffisance aortique/étiologie , Sténose aortique/thérapie , Valve aortique/anatomopathologie , Calcinose/thérapie , Calcium/analyse , Cathétérisme cardiaque/effets indésirables , Implantation de valve prothétique cardiaque/effets indésirables , Sclérose/thérapie , Sujet âgé , Sujet âgé de 80 ans ou plus , Valve aortique/imagerie diagnostique , Valve aortique/métabolisme , Sténose aortique/imagerie diagnostique , Sténose aortique/métabolisme , Calcinose/imagerie diagnostique , Calcinose/métabolisme , Échocardiographie transoesophagienne , Femelle , Implantation de valve prothétique cardiaque/méthodes , Humains , Interprétation d'images assistée par ordinateur , Mâle , Valeur prédictive des tests , Études rétrospectives , Facteurs de risque , Sclérose/imagerie diagnostique , Sclérose/métabolisme , Indice de gravité de la maladie , Facteurs temps , Résultat thérapeutiqueSujet(s)
Cathétérisme cardiaque/instrumentation , Cathétérisme cardiaque/méthodes , Implantation de valve prothétique cardiaque/instrumentation , Insuffisance mitrale/diagnostic , Insuffisance mitrale/chirurgie , Radiographie interventionnelle/méthodes , Instruments chirurgicaux , Prothèse valvulaire cardiaque , Implantation de valve prothétique cardiaque/méthodes , Humains , Radiographie interventionnelle/instrumentationRÉSUMÉ
Real-time 3D echocardiography is one of the most important developments in the field of non-invasive cardiac imaging within the last years. To investigate whether this new technology can be considered as a standard method the current guidelines and recommendations were reviewed. In the field of left ventricular function assessment, evaluation of mitral valve pathologies and peri-interventional monitoring of percutaneous valve repair procedures 3D echocardiography plays a major role. For other clinical applications, such as right heart assessment, congenital heart disease and stress echocardiography, a high potential is seen but evidence is currently too weak for general recommendations. However, in the near future no echo laboratory will be working without 3D modalities.
Sujet(s)
Cardiologie/normes , Échocardiographie tridimensionnelle/normes , Guides de bonnes pratiques cliniques comme sujet , Radiologie/normes , Cardiologie/tendances , Échocardiographie tridimensionnelle/tendances , Allemagne , Internationalité , Radiologie/tendancesRÉSUMÉ
Hypertension is a well-known risk factor for major cardiovascular events. Despite advances in medical therapy, sufficient treatment of hypertension remains unsatisfying in a substantial number of patients and is therefore one of the main challenges in modern medicine. In Germany 5-15 % of patients with hypertension suffer from resistant hypertension with elevated blood pressure despite the use of at least three antihypertensive drugs. Additionally patients often suffer from side effects. In patients with resistant hypertension the important role of the sympathetic nervous system with increased sympathetic activity is well known. In the past surgical sympathectomy with extended removal of sympathetic ganglia was performed to reduce blood pressure in patients with malignant hypertension. The positive effect of this highly invasive procedure on blood pressure led to the development of new strategies for the treatment of uncontrolled hypertension. One of the novel procedures includes catheter-based renal sympathetic denervation. The most common system is the radiofrequency ablation catheter (Symplicity®, Medtronic, Minneapolis, USA) which ablates the nerve fibers in the adventitia of the renal arteries by using high-frequency energy. As the results of the Symplicity trials (HTN-1 and HTN-2) showed significant reduction of systolic and diastolic blood pressure after renal denervation there is growing interest in this novel procedure. Moreover, by reducing the sympathetic activity after renal denervation early results indicate a positive impact on glucose metabolism, sleep apnea syndrome, as well as heart and renal failure. These effects led to the development of many different devices for renal denervation; however, trials with a higher number of patients and longer follow-up need to confirm these initially promising results and the value of newer devices. Until then renal denervation should not be regarded as standard therapy for arterial hypertension or an alternative to medical antihypertensive treatment and should be reserved for selected patients with resistant hypertension and specialized medical centres.
Sujet(s)
Ablation par cathéter/tendances , Prévision , Hypertension artérielle/chirurgie , Rein/innervation , Rein/chirurgie , Sympathectomie/méthodes , Sympathectomie/tendances , Humains , Résultat thérapeutiqueRÉSUMÉ
As a potential alternative to long-term oral anticoagulation with vitamin K antagonists in patients with atrial fibrillation, the interventional left atrial appendage occlusion has shown to be non-inferior regarding neurological events. With the new oral direct factor II and factor Xa inhibitors playing an emerging role in stroke prophylaxis, an individual treatment strategy has to be found weighing bleeding and stroke risk against the peri-interventional complication rate based on established risk scores.
Sujet(s)
Anticoagulants/administration et posologie , Auricule de l'atrium/chirurgie , Fibrillation auriculaire/complications , Fibrillation auriculaire/traitement médicamenteux , Accident vasculaire cérébral/étiologie , Accident vasculaire cérébral/prévention et contrôle , Vitamine K/antagonistes et inhibiteurs , Administration par voie orale , Anticoagulants/effets indésirables , Médecine factuelle , HumainsSujet(s)
Endocardite bactérienne/diagnostic , Abcès/diagnostic , Abcès/traitement médicamenteux , Abcès/microbiologie , Antibactériens/effets indésirables , Antibactériens/usage thérapeutique , Techniques bactériologiques , Association de médicaments , Échocardiographie tridimensionnelle , Endocardite bactérienne/traitement médicamenteux , Endocardite bactérienne/microbiologie , Europe , Adhésion aux directives , Humains , Tomodensitométrie multidétecteurs , Terminologie comme sujetRÉSUMÉ
To account for the current evidence in the field of infective endocarditis and to harmonize deviant national guidelines, in 2009 the European Society of Cardiology published novel recommendations on the prevention, diagnosis and treatment of infective endocarditis.The most important changes can be found concerning antimicrobial prophylaxis for endocarditis, the antimicrobial treatment of endocarditis caused by S. aureus and the indications for surgical treatment.Due to the weak evidence about prophylactic administration of antibiotics before procedures at risk for bacteraemia to prevent infective endocarditis, the novel guidelines recommend prophylaxis only in patients with the highest risk for infection and lethal course of endocarditis. These are patients with prosthetic valves or prosthetic material used for cardiac repair, patients with previous endocarditis and patients with congenital heart disease. A narrow definition of procedures at risk was proposed only including dental procedures requiring manipulation of the gingival or periapical region of teeth.For endocarditis caused by S. aureus an additional gentamicin administration was previously recommended but this is now seen only as optional due to its nephrotoxicity. In methicillin-resistant strains daptomycin is a possible alternative to vancomycin. In strains susceptible to methicillin, beta-lactamic antibiotics were definitively preferred than the usage of vancomycin due to better outcome. The current guidelines recommend definitive timing and risk constellations for surgical treatment of infective endocarditis. For example, cardiac shock due to valvular lesions refractory to medical treatment should give rise to an emergency intervention within 24 h. Other indication groups contain uncontrolled infection and prevention of embolism and indications were defined as urgent or elective depending on the clinical situation.
Sujet(s)
Antibactériens/usage thérapeutique , Endocardite bactérienne/diagnostic , Endocardite bactérienne/thérapie , Antibactériens/effets indésirables , Bactériémie/complications , Procédures de chirurgie cardiaque , Association thérapeutique , Daptomycine/effets indésirables , Daptomycine/usage thérapeutique , Relation dose-effet des médicaments , Calendrier d'administration des médicaments , Échocardiographie tridimensionnelle , Échocardiographie transoesophagienne , Endocardite bactérienne/prévention et contrôle , Europe , Gentamicine/effets indésirables , Gentamicine/usage thérapeutique , Cardiopathies congénitales/complications , Implantation de valve prothétique cardiaque , Humains , Staphylococcus aureus résistant à la méticilline , Complications postopératoires/diagnostic , Complications postopératoires/thérapie , Prévention secondaire , Infections à staphylocoques/prévention et contrôle , Infections à staphylocoques/chirurgie , Infections à staphylocoques/thérapie , Résistance à la vancomycineRÉSUMÉ
Infective endocarditis is an infection of cardiovascular structures which is typically caused by bacteria. Despite recent medical advances mortality reaches up to 26% which is even higher with mortality rates of up to 84% in complex cases leading to admission to intensive care units. The diagnosis is based on positive blood culture results with identical microorganisms and the demonstration of endocardial involvement. A rapid initiation of an adequate therapeutic regimen is important to prevent the patients from severe complications such as heart failure, uncontrolled infection or septic embolism. An early and targeted initiation of an antibiotic therapy after microbiologic testing is crucial for therapeutic success. The immediate cooperation of Cardiologists, Microbiologists, Infectious Disease Specialists and Cardiac Surgeons is highly recommended to allow an adequate medical and surgical treatment without delay in complex cases. Antibiotic treatment has to be continued postoperatively.
Sujet(s)
Service hospitalier d'urgences , Endocardite bactérienne/diagnostic , Antibactériens/usage thérapeutique , Bactériémie/diagnostic , Bactériémie/mortalité , Bactériémie/thérapie , Techniques bactériologiques , Association thérapeutique , Comportement coopératif , Soins de réanimation , Échocardiographie , Échocardiographie transoesophagienne , Endocardite bactérienne/mortalité , Endocardite bactérienne/thérapie , Implantation de valve prothétique cardiaque , Humains , Communication interdisciplinaire , Staphylococcus aureus résistant à la méticilline , Équipe soignante , Infections à staphylocoques/diagnostic , Infections à staphylocoques/mortalité , Infections à staphylocoques/thérapie , Taux de survieRÉSUMÉ
Intramural hematoma (IMH) of the aorta and penetrating aortic ulcer (PAU) are important variant forms of classic double-barrel aortic dissection in patients presenting with acute aortic syndrome. Recent insights provided by modern high-resolution imaging are currently challenging previous pathophysiologic concepts underlying IMH and PAU, suggesting a close relationship of both entities. Thoracic endovascular aortic repair (TEVAR) offers a less invasive approach to the treatment of affected patients with very encouraging early to midterm results. This review discusses current indication for TEVAR in IMH and PAU patients in the view of an improved understanding of these diseases.
Sujet(s)
Aorte thoracique/chirurgie , Anévrysme de l'aorte thoracique/chirurgie , Maladies de l'aorte/chirurgie , /chirurgie , Implantation de prothèses vasculaires , Hématome/chirurgie , Ulcère/chirurgie , Maladie aigüe , /diagnostic , Aorte thoracique/anatomopathologie , Anévrysme de l'aorte thoracique/diagnostic , Maladies de l'aorte/diagnostic , Aortographie/méthodes , Prothèse vasculaire , Implantation de prothèses vasculaires/instrumentation , Échocardiographie transoesophagienne , Hématome/diagnostic , Humains , Tomographie par émission de positons , Endoprothèses , Syndrome , Tomodensitométrie , Résultat thérapeutique , Ulcère/diagnosticRÉSUMÉ
HISTORY: A 64-year old male marathon runner noted during training an asymptomatic sudden increase in heart rate as recorded on his heart rate monitor. But this was not verifiable on subsequent Holter-ECG monitoring. However, treadmill exercise testing revealed unexpected signs of ischemia, which required further diagnostic tests. INVESTIGATIONS: Cardiac computed tomography (CT) demonstrated advanced coronary atherosclerosis, with suspected morphologically significant stenosis after contrast injection. Because of the absence of angina, a myocardial perfusion scintigraphy was done which gave no evidence of ischemia, and there was no late enhancement on magnetic resonance imaging. In view of these findings invasive coronary angiography was not performed. TREATMENT AND COURSE: The patient received aggressive risk modifying therapy. He is still running regularly event-free after nine months. CONCLUSION: This case shows that the use of modern non-invasive cardiovascular imaging can have an impact in preventive clinical decision making.
Sujet(s)
Maladie des artères coronaires/diagnostic , Sténose coronarienne/diagnostic , Mort subite cardiaque/prévention et contrôle , Infarctus du myocarde/prévention et contrôle , Course à pied/physiologie , Coronarographie , Maladie des artères coronaires/physiopathologie , Sténose coronarienne/physiopathologie , Échocardiographie , Électrocardiographie ambulatoire , Épreuve d'effort , Rythme cardiaque , Humains , Angiographie par résonance magnétique , Mâle , Adulte d'âge moyen , Imagerie de perfusion myocardique , Appréciation des risques , Tachycardie/diagnostic , Tachycardie/étiologie , Tomodensitométrie/méthodesRÉSUMÉ
Infective endocarditis is an infection of cardiovascular structures which is typically caused by bacteria. Despite recent medical advances mortality ranges from 20 to 25%. Without treatment, IE is a lethal disease. The mortality rate depends on several clinical factors including the causative microorganism, the time of diagnosis, and the initiation of an adequate therapeutic regimen. The diagnosis is based on positive blood culture results with identical microorganisms and the demonstration of endocardial involvement. Negative blood cultures represent a diagnostic challenge which may increase the importance of diagnostic tools such as serology and PCR. An early and targeted initiation of an antibiotic therapy after microbiologic testing is crucial for therapeutic success. The immediate cooperation of Cardiologists, Microbiologists, Infectious Disease Specialists and Cardiac Surgeons is highly recommended to allow an adequate medical and surgical treatment in complex cases.Prophylaxis appears reasonable due to the inherent high mortality. The efficacy of an antibiotic prophylaxis is, nevertheless, not rigorously proven. Even if a high efficacy is assumed, the number needed to treat is extremely high due to the low individual risk. Thus, current guidelines recommend an antibiotic prophylaxis only in patients with a high risk for an adverse outcome.
Sujet(s)
Antibactériens/usage thérapeutique , Endocardite bactérienne/traitement médicamenteux , Endocardite/traitement médicamenteux , Antibactériens/effets indésirables , Antibioprophylaxie , Échocardiographie , Échocardiographie transoesophagienne , Endocardite/diagnostic , Endocardite/prévention et contrôle , Endocardite bactérienne/diagnostic , Endocardite bactérienne/prévention et contrôle , Humains , Tests de sensibilité microbienne , Réaction de polymérisation en chaîne , Facteurs de risqueRÉSUMÉ
The incidental detection of a persistent left vena cava superior during insertion of a pulmonary artery catheter in a patient with acute respiratory distress syndrome (ARDS) prior to extracorporeal membrane oxygenation (ECMO) therapy is reported. A persistent left vena cava superior is the most frequent thoracic malformation and can be associated with other malformations such as congenital heart disease. Therefore, further diagnostic evaluation is needed especially in pulmonary hypertension and ARDS. Anaesthesiologists should be aware of the specific aspects associated with a persistent left vena cava superior.